| Name | Recombinant Human IL-28 R alpha/IFN-lambda R1 Fc Chimera, CF |
|---|---|
| Supplier | R&D Systems |
| Catalog | 5260-MR |
| Category | Protein |
| Prices | $329.00 |
| Sizes | 50 µg |
| Species Reactivities | Human |
| Nature | Recombinant |
| Source | Mouse myeloma cell line, NS0-derived Human IL-28 R alpha (Arg21 - Ala228) Accession # Q8IU57 IEGRMD Human IgG 1 (Pro100 - Lys330) N-terminus C-terminus |
| Purity | >95%, by SDS-PAGE under reducing conditions and visualized by silver stain |
| Bioactivity | Measured by its binding ability in a functional ELISA. In a 100 μL reaction mixture containing rhIL-28 R alpha /Fc Chimera at 1 μg/mL and rhIL-28A (Catalog # 1587-IL) dilutions at 1-1000 ng/mL, the concentration of rhIL-28A that produces 50% of the optimal binding response is found to be approximately 40-200 ng/mL. |
| Endotoxin | <0.01 EU per 1 μg of the protein by the LAL method. |
| SwissProt/Accession | Q8IU57 |
| Gene | IFNLR1 |
| Sequence | Arg21 |
| Supplier Page | Shop |